The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
High-risk prostate cancer—classification and therapy
Open accessAbstract
High-risk disease accounts for approximately 15% of prostate cancer diagnoses, but the current definitions include a heterogeneous group of patients with a range of prognoses. High-risk prostate cancers have the potential to progress to a lethal phenotype that can be fatal, in marked contrast to low-risk tumours deemed suitable for active surveillance,. The optimal management of this patient sub-group is evolving. A refined classification scheme is needed to enable the early and accurate identification of high-risk disease so that more effective treatment paradigms can be developed. Several principles have been established from clinical trials and are discussed in this review, while other questions remain unanswered. This review critically evaluates the existing literature focused on defining the high-risk population, the management therein, and future directions to optimize care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Scher, H. I., Fizazi, K., Saad, F., Taplin, M.-E., Sternberg, C. N., Miller, K., de Wit, R., Mulders, P., Chi, K. N., Shore, N. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207506 · Cited by 4,586
Self-citationD'Amico, A. V. (1998) · JAMA · doi:10.1001/jama.280.11.969 · Cited by 4,523
Abiraterone and Increased Survival in Metastatic Prostate Cancer
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407
Self-citationAlpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213755 · Cited by 3,408
de Bono, J. S., Oudard, S., Ozguroglu, M., Hansen, S., Machiels, J.-P., Kocak, I., Gravis, G., Bodrogi, I., Mackenzie, M. J., Shen, L., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61389-x · Cited by 3,318
EAU Guidelines on Prostate Cancer
Heidenreich, A., Aus, G., Bolla, M., Joniau, S., Matveev, V. B., Schmid, H. P., & Zattoni, F. (2008) · European Urology · doi:10.1016/j.eururo.2007.09.002 · Cited by 3,136
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Ryan, C. J., Smith, M. R., de Bono, J. S., Molina, A., Logothetis, C. J., de Souza, P., Fizazi, K., Mainwaring, P., Piulats, J. M., Ng, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209096 · Cited by 2,796
Self-citationRadical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Wilt, T. J., Brawer, M. K., Jones, K. M., Barry, M. J., Aronson, W. J., Fox, S., Gingrich, J. R., Wei, J. T., Gilhooly, P., Grob, B. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113162 · Cited by 1,770
Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09408-4 · Cited by 1,686
Heidenreich, A., Bellmunt, J., Bolla, M., Joniau, S., Mason, M., Matveev, V., Mottet, N., Schmid, H.-P., van der Kwast, T., Wiegel, T., et al. (2011) · European Urology · doi:10.1016/j.eururo.2010.10.039 · Cited by 1,492
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455
Fizazi, K., Scher, H. I., Molina, A., Logothetis, C. J., Chi, K. N., Jones, R. J., Staffurth, J. N., North, S., Vogelzang, N. J., Saad, F., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70379-0 · Cited by 1,384
Self-citationA Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer
Kattan, M. W., Eastham, J. A., Stapleton, A. M. F., Wheeler, T. M., & Scardino, P. T. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.10.766 · Cited by 1,242
Thompson, I. M., Tangen, C. M., Paradelo, J., Lucia, M. S., Miller, G., Troyer, D., Messing, E., Forman, J., Chin, J., Swanson, G., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2008.11.032 · Cited by 1,227
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Thompson, I., Thrasher, J. B., Aus, G., Burnett, A. L., Canby-Hagino, E. D., Cookson, M. S., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.003 · Cited by 1,113
Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
Cooperberg, M. R., Broering, J. M., & Carroll, P. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.0133 · Cited by 1,006
Duration of Androgen Suppression in the Treatment of Prostate Cancer
Bolla, M., de Reijke, T. M., Van Tienhoven, G., Van den Bergh, A. C. M., Oddens, J., Poortmans, P. M. P., Gez, E., Kil, P., Akdas, A., Soete, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810095 · Cited by 970
Peeters, S. T. H., Heemsbergen, W. D., Koper, P. C. M., van Putten, W. L. J., Slot, A., Dielwart, M. F. H., Bonfrer, J. M. G., Incrocci, L., & Lebesque, J. V. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2530 · Cited by 966
Zelefsky, M., Leibel, S., Gaudin, P., Kutcher, G., Fleshner, N., Venkatramen, E. S., Reuter, V., Fair, W., Ling, C. C., & Fuks, Z. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00091-1 · Cited by 924
Pilepich, M. V., Winter, K., Lawton, C. A., Krisch, R. E., Wolkov, H. B., Movsas, B., Hug, E. B., Asbell, S. O., & Grignon, D. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.08.047 · Cited by 913
Dearnaley, D. P., Sydes, M. R., Graham, J. D., Aird, E. G., Bottomley, D., Cowan, R. A., Huddart, R. A., Jose, C. C., Matthews, J. H., Millar, J., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70143-2 · Cited by 905
Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer: A Randomized Clinical Trial
Thompson, I. M., Tangen, C. M., Paradelo, J., Lucia, M. S., Miller, G., Troyer, D., Messing, E., Forman, J., Chin, J., Swanson, G., et al. (2006) · JAMA · doi:10.1001/jama.296.19.2329 · Cited by 897
Stephenson, A. J., Scardino, P. T., Kattan, M. W., Pisansky, T. M., Slawin, K. M., Klein, E. A., Anscher, M. S., Michalski, J. M., Sandler, H. M., Lin, D. W., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9607 · Cited by 888
Widmark, A., Klepp, O., Solberg, A., Damber, J.-E., Angelsen, A., Fransson, P., Lund, J.-Å., Tasdemir, I., Hoyer, M., Wiklund, F., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61815-2 · Cited by 876
Bolla, M., van Poppel, H., Tombal, B., Vekemans, K., Da Pozzo, L., de Reijke, T. M., Verbaeys, A., Bosset, J.-F., van Velthoven, R., Colombel, M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61253-7 · Cited by 867
前立腺癌のEAUガイドライン。パート1:臨床的限局性疾患のスクリーニング,診断および治療
Heidenreich, A., Bellmunt, J., Bolla, M., et al. (2011) · European Urology · Cited by 866
Variations in Morbidity after Radical Prostatectomy
Begg, C. B., Riedel, E. R., Bach, P. B., Kattan, M. W., Schrag, D., Warren, J. L., & Scardino, P. T. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa011788 · Cited by 840
Wiegel, T., Bottke, D., Steiner, U., Siegmann, A., Golz, R., Störkel, S., Willich, N., Semjonow, A., Souchon, R., Stöckle, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9563 · Cited by 825
COOPERBERG, M. R., PASTA, D. J., ELKIN, E. P., LITWIN, M. S., LATINI, D. M., Du CHANE, J., & CARROLL, P. R. (2005) · Journal of Urology · doi:10.1097/01.ju.0000158155.33890.e7 · Cited by 772
Zietman, A. L., Bae, K., Slater, J. D., Shipley, W. U., Efstathiou, J. A., Coen, J. J., Bush, D. A., Lunt, M., Spiegel, D. Y., Skowronski, R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8475 · Cited by 735
D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Blank, K., Broderick, G. A., Tomaszewski, J. E., Renshaw, A. A., Kaplan, I., Beard, C. J., et al. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61700-2 · Cited by 713
Horwitz, E. M., Bae, K., Hanks, G. E., Porter, A., Grignon, D. J., Brereton, H. D., Venkatesan, V., Lawton, C. A., Rosenthal, S. A., Sandler, H. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9021 · Cited by 688
Roach, M., Bae, K., Speight, J., Wolkov, H. B., Rubin, P., Lee, R. J., Lawton, C., Valicenti, R., Grignon, D., & Pilepich, M. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9881 · Cited by 649
Self-citationPredicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
Eggener, S. E., Scardino, P. T., Walsh, P. C., Han, M., Partin, A. W., Trock, B. J., Feng, Z., Wood, D. P., Eastham, J. A., Yossepowitch, O., et al. (2011) · Journal of Urology · doi:10.1016/j.juro.2010.10.057 · Cited by 640
Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
Hussain, M., Tangen, C. M., Berry, D. L., Higano, C. S., Crawford, E. D., Liu, G., Wilding, G., Prescott, S., Kanaga Sundaram, S., Small, E. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212299 · Cited by 580
Warde, P., Mason, M., Ding, K., Kirkbride, P., Brundage, M., Cowan, R., Gospodarowicz, M., Sanders, K., Kostashuk, E., Swanson, G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61095-7 · Cited by 579
Bianco, F. J., Scardino, P. T., & Eastham, J. A. (2005) · Urology · doi:10.1016/j.urology.2005.06.116 · Cited by 553
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Ding, Z., Wu, C.-J., Chu, G. C., Xiao, Y., Ho, D., Zhang, J., Perry, S. R., Labrot, E. S., Wu, X., Lis, R., et al. (2011) · Nature · doi:10.1038/nature09677 · Cited by 515
Pelvic Lymph Node Dissection in Prostate Cancer
Briganti, A., Blute, M. L., Eastham, J. H., Graefen, M., Heidenreich, A., Karnes, J. R., Montorsi, F., & Studer, U. E. (2009) · European Urology · doi:10.1016/j.eururo.2009.03.012 · Cited by 501
Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
Crook, J. M., O'Callaghan, C. J., Duncan, G., Dearnaley, D. P., Higano, C. S., Horwitz, E. M., Frymire, E., Malone, S., Chin, J., Nabid, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201546 · Cited by 499
Ward, J. F., Slezak, J. M., Blute, M. L., Bergstralh, E. J., & Zincke, H. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05394.x · Cited by 473
Cooperberg, M. R., Hilton, J. F., & Carroll, P. R. (2011) · Cancer · doi:10.1002/cncr.26169 · Cited by 457
70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial
Beckendorf, V., Guerif, S., Le Prisé, E., Cosset, J.-M., Bougnoux, A., Chauvet, B., Salem, N., Chapet, O., Bourdain, S., Bachaud, J.-M., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.03.049 · Cited by 452
Nguyen, P. L., Je, Y., Schutz, F. A. B., Hoffman, K. E., Hu, J. C., Parekh, A., Beckman, J. A., & Choueiri, T. K. (2011) · JAMA · doi:10.1001/jama.2011.1745 · Cited by 432
Outcomes of Localized Prostate Cancer Following Conservative Management
Lu-Yao, G. L. (2009) · JAMA · doi:10.1001/jama.2009.1348 · Cited by 430
Stephenson, A. J., Kattan, M. W., Eastham, J. A., Bianco, F. J., Yossepowitch, O., Vickers, A. J., Klein, E. A., Wood, D. P., & Scardino, P. T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2501 · Cited by 419
Sathya, J. R., Davis, I. R., Julian, J. A., Guo, Q., Daya, D., Dayes, I. S., Lukka, H. R., & Levine, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.154 · Cited by 396
Impact of Age at Diagnosis on Prostate Cancer Treatment and Survival
Bechis, S. K., Carroll, P. R., & Cooperberg, M. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2075 · Cited by 392
Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO Guideline
Thompson, I. M., Valicenti, R. K., Albertsen, P., Davis, B. J., Goldenberg, S. L., Hahn, C., Klein, E., Michalski, J., Roach, M., Sartor, O., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.05.032 · Cited by 391
Self-citationCooperberg, M. R., Simko, J. P., Cowan, J. E., Reid, J. E., Djalilvand, A., Bhatnagar, S., Gutin, A., Lanchbury, J. S., Swanson, G. P., Stone, S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.4396 · Cited by 351
Knezevic, D., Goddard, A. D., Natraj, N., Cherbavaz, D. B., Clark-Langone, K. M., Snable, J., Watson, D., Falzarano, S. M., Magi-Galluzzi, C., Klein, E. A., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-690 · Cited by 339
Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis
Cooperberg, M. R., Broering, J. M., & Carroll, P. R. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp122 · Cited by 336
Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical Prostatectomy
Heidenreich, A., Ohlmann, C. H., & Polyakov, S. (2007) · European Urology · doi:10.1016/j.eururo.2007.04.020 · Cited by 325
Zelefsky, M. J., Eastham, J. A., Cronin, A. M., Fuks, Z., Zhang, Z., Yamada, Y., Vickers, A., & Scardino, P. T. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.2265 · Cited by 310
Cormie, P., Galvão, D. A., Spry, N., Joseph, D., Chee, R., Taaffe, D. R., Chambers, S. K., & Newton, R. U. (2015) · BJU International · doi:10.1111/bju.12646 · Cited by 277
Boorjian, S. A., Karnes, R. J., Viterbo, R., Rangel, L. J., Bergstralh, E. J., Horwitz, E. M., Blute, M. L., & Buyyounouski, M. K. (2011) · Cancer · doi:10.1002/cncr.25900 · Cited by 272
Kuban, D. A., Levy, L. B., Cheung, M. R., Lee, A. K., Choi, S., Frank, S., & Pollack, A. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.01.006 · Cited by 257
Peng, Y., Jiang, Y., Yang, C., Brown, J. B., Antic, T., Sethi, I., Schmid-Tannwald, C., Giger, M. L., Eggener, S. E., & Oto, A. (2013) · Radiology · doi:10.1148/radiol.13121454 · Cited by 250
Touijer, K. A., Mazzola, C. R., Sjoberg, D. D., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.03.053 · Cited by 245
Gardner, J. R., Livingston, P. M., & Fraser, S. F. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.5523 · Cited by 243
Clinical states in prostate cancer: toward a dynamic model of disease progression
Scher, H. I., & Heller, G. (2000) · Urology · doi:10.1016/s0090-4295(99)00471-9 · Cited by 232
Self-citationNam, R. K., Cheung, P., Herschorn, S., Saskin, R., Su, J., Klotz, L. H., Chang, M., Kulkarni, G. S., Lee, Y., Kodama, R. T., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70606-5 · Cited by 224
Limits of observational data in determining outcomes from cancer therapy
Giordano, S. H., Kuo, Y., Duan, Z., Hortobagyi, G. N., Freeman, J., & Goodwin, J. S. (2008) · Cancer · doi:10.1002/cncr.23452 · Cited by 206
Yossepowitch, O., Eggener, S. E., Serio, A. M., Carver, B. S., Bianco, F. J., Scardino, P. T., & Eastham, J. A. (2008) · European Urology · doi:10.1016/j.eururo.2007.10.008 · Cited by 193
Zelefsky, M. J., Reuter, V. E., Fuks, Z., Scardino, P., & Shippy, A. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.11.063 · Cited by 184
Valicenti, R. K., Thompson, I., Albertsen, P., Davis, B. J., Goldenberg, S. L., Wolf, J. S., Sartor, O., Klein, E., Hahn, C., Michalski, J., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.05.029 · Cited by 173
Self-citationSpahn, M., Joniau, S., Gontero, P., Fieuws, S., Marchioro, G., TOMBAL, B. F., Kneitz, B., Hsu, C., Eeckt, K. V. D., Bader, P., et al. (2010) · European Urology · doi:10.1016/j.eururo.2010.03.001 · Cited by 168
Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
Jang, T. L. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.1 · Cited by 163
Androgen deprivation therapy: evidence‐based management of side effects
Ahmadi, H., & Daneshmand, S. (2013) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11774.x · Cited by 160
Lane, J. A., Hamdy, F. C., Martin, R. M., Turner, E. L., Neal, D. E., & Donovan, J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.016 · Cited by 149
Kattan, M. W., Zeléfsky, M. J., Kupelian, P. A., Cho, D., Scardino, P. T., FUKS, Z. Y., & Leibel, S. A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.046 · Cited by 146
Moinpour, C. M., Hayden, K. A., Unger, J. M., Thompson, I. M., Redman, M. W., Canby‐Hagino, E., Higgins, B., Sullivan, J. W., Lemmon, D., Breslin, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4505 · Cited by 145
Lin, D. W., Newcomb, L. F., Brown, E. C., Brooks, J. D., Carroll, P. R., Feng, Z., Gleave, M. E., Lance, R. S., Sanda, M. G., Thompson, I. M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3283 · Cited by 139
Predictors of patient preferences and treatment choices for localized prostate cancer
Sommers, B. D., Beard, C. J., D'Amico, A. V., Kaplan, I. D., Richie, J. P., & Zeckhauser, R. (2008) · Cancer · doi:10.1002/cncr.23807 · Cited by 137
Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRS
Tiwari, P., Kurhanewicz, J. V., & Madabhushi, A. (2012) · Medical Image Analysis · doi:10.1016/j.media.2012.10.004 · Cited by 111
Bhojani, N., Umberto Capitanio, A., Suardi, N. R., Claudio Jeldres, A., Hendrik Isbarn, A., Shariat, S. F., Graefen, M., Arjane, P., Duclos, A. J., Lattouf, J., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.011 · Cited by 105
Secondary Cancer After Radiotherapy for Prostate Cancer: Should We Be More Aware of the Risk?
Boström, P. J., & Soloway, M. S. (2007) · European Urology · doi:10.1016/j.eururo.2007.07.002 · Cited by 98
Feifer, A. H., Elkin, E. B., Lowrance, W. T., Denton, B. T., Jacks, L. M., Yee, D. S., Coleman, J., Laudone, V. P., Scardino, P. T., & Eastham, J. A. (2011) · Cancer · doi:10.1002/cncr.25981 · Cited by 81
Zeléfsky, M. J., Leibel, S. A., Gaudin, P. B., Kutcher, G. J., Fleshner, N. E., Venkatramen, E. S., Reuter, V. E., Fair, W. R., Ling, C. C., FUKS, Z. Y., et al. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68362-0 · Cited by 80
D'Amico, A. V., Moran, B. J., Braccioforte, M. H., Dosoretz, D. E., Salenius, S. A., Katin, M. J., Ross, R., & Chen, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.3992 · Cited by 77
Androgen Deprivation Therapy and Cardiovascular Risk
Punnen, S., Cooperberg, M. R., Sadetsky, N., & Carroll, P. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.1494 · Cited by 75
Saylor, P. J., Keating, N. L., & Smith, M. R. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0968-y · Cited by 68
Zeléfsky, M. J., Chou, J. F., Pei, X., Yamada, Y. J., Kollmeier, M. A., Cox, B. W., Zhang, Z., Schechter, M., Cohen, G. N., & Zaider, M. (2011) · Brachytherapy · doi:10.1016/j.brachy.2011.08.003 · Cited by 59
Yakar, D., Debats, O. A., Bomers, J. G. R., Schouten, M. G., Vos, P., van Lin, E. N. J. T., Fütterer, J. J., & Barentsz, J. O. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22790 · Cited by 58
Nichol, A., Warde, P. R., & Bristow, R. G. (2005) · Cancer · doi:10.1002/cncr.21257 · Cited by 56
Arcangeli, G., Strigari, L., Arcangeli, S., Petrongari, M. G., Saracino, B., Gomellini, S., Papalia, R., Simone, G., Carli, P. D., & Gallucci, M. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.045 · Cited by 49
Roach, M., WEINBERG, V. K., Nash, M., Sandler, H. M., McLaughlin, P. W., & Kattan, M. W. (2006) · The Journal of Urology · doi:10.1016/j.juro.2006.06.081 · Cited by 45
Self-citationOutcome of Prostate Cancer Patients with Initial PSA ≥ 20 ng/ml Undergoing Radical Prostatectomy
Zwergel, U., Suttmann, H., Schroeder, T. A., Siemer, S., Wullich, B., Kamradt, J., Lehmann, J., & Stöeckle, M. (2007) · European Urology · doi:10.1016/j.eururo.2007.03.056 · Cited by 44
Advances in Robotic-Assisted Radical Prostatectomy over Time
Jacobs, E. F. P., Boris, R. S., & Masterson, T. A. (2013) · Prostate Cancer · doi:10.1155/2013/902686 · Cited by 29
Fang, L. C., Merrick, G. S., Butler, W. M., Galbreath, R. W., Murray, B. C., Reed, J. L., Adamovich, E., & Wallner, K. E. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.07.006 · Cited by 25
Vargas, C., Martínez, A., Galalae, R. M., Demanes, J., Harsolia, A., Schour, L., Nuernberg, N., & Gonzalez, J. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500882 · Cited by 23
Predicting high-risk disease using tissue biomarkers
Donovan, M. J., & Cordon‐Cardo, C. (2013) · Current Opinion in Urology · doi:10.1097/mou.0b013e32835f89cc · Cited by 22
Creak, A., Hall, E., Horwich, A., Eeles, R. A., Khoo, V. S., Huddart, R. A., Parker, C. C., Griffin, C. L., Bidmead, M. A. M., Warrington, J. I., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.394 · Cited by 22
Roach, M. (2007) · Strahlentherapie und Onkologie · doi:10.1007/s00066-007-2011-8 · Cited by 21
Self-citationAdvances in the management of high‐risk localised and metastatic prostate cancer
Bellmunt, J., Attard, G., Bahl, A. K., Huland, H., Klotz, L. H., Kuban, D. A., Oudard, S. M., & Watson, R. W. G. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10871.x · Cited by 12
Cited by
Alternative splicing and related RNA binding proteins in human health and disease
Tao, Y., Zhang, Q., Wang, H., Yang, X., & Mu, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01734-2 · Cited by 320
Okada, T., Uto, K., Aoyagi, T., & Ebara, M. (2016) · Biomaterials Science · doi:10.1039/c5bm00375j · Cited by 20
Metadata
- Authors
- Chang, A. J., Autio, K. A., Roach, M., & Scher, H. I.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2014-05-20
- Volume
- 11
- Issue
- 6
- Pages
- 308-323
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W1603862075
- Cited by
- 500
- References
- 98
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.